| P50 | author | David W. Threadgill | Q42306006 |
| P2093 | author name string | Eric G Neilson | |
| | Raymond C Harris | |
| | Jianchun Chen | |
| | Feng Sha | |
| | T Alp Ikizler | |
| | C Chad Quarles | |
| | Kojiro Nagai | |
| | Jian-Kang Chen | |
| | Masayo Hino | |
| | Jinxian Xu | |
| | David Plieth | |
| P2860 | cites work | The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 |
| | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 |
| | Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton | Q24299873 |
| | Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive | Q24306328 |
| | Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids | Q24306330 |
| | The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1 | Q24315566 |
| | Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN | Q24322051 |
| | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
| | mTOR signaling in growth control and disease | Q24634174 |
| | RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1 | Q24682697 |
| | PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 |
| | Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting | Q27940116 |
| | PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney | Q40125775 |
| | Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy | Q40287304 |
| | hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase | Q40392574 |
| | Progression of renal disease and renal hypertrophy | Q40543219 |
| | The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. | Q40789796 |
| | Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells | Q41000352 |
| | Nephron mass as a risk factor for progression of renal disease | Q41667489 |
| | Amino acid availability regulates p70 S6 kinase and multiple translation factors | Q41913722 |
| | S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy | Q42454439 |
| | Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy | Q44903310 |
| | Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. | Q46011005 |
| | Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy | Q46402341 |
| | Influence of amino acid availability on protein turnover in perfused skeletal muscle | Q51663760 |
| | Pattern of expression of gamma-glutamyl transpeptidase in rat liver and kidney during development: study by immunochemistry and in situ hybridization. | Q53506982 |
| | Compensatory and obligatory renal growth in rats | Q54697629 |
| | Effects of Maternal Nephrectomy on Fœtal Kidneys | Q59145619 |
| | Macromolecular metabolism in renal compensatory hypertrophy. I. Protein synthesis | Q71218053 |
| | Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B | Q28116107 |
| | A mammalian protein targeted by G1-arresting rapamycin-receptor complex | Q28243712 |
| | Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy | Q28263676 |
| | Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome | Q28307704 |
| | Pten is essential for embryonic development and tumour suppression | Q28509238 |
| | Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN | Q28513537 |
| | PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway | Q28588309 |
| | Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha | Q28616168 |
| | Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism | Q29614737 |
| | Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 |
| | TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia | Q29618875 |
| | PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? | Q29619633 |
| | Akt regulates growth by directly phosphorylating Tsc2 | Q29620397 |
| | Size does matter: will knockout of p21(WAF1/CIP1) save the kidney by limiting compensatory renal growth? | Q33732373 |
| | Molecular mechanisms of renal hypertrophy: role of p27Kip1. | Q33742702 |
| | Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. | Q34063643 |
| | Tuberous sclerosis: from tubers to mTOR. | Q34173640 |
| | Akt/protein kinase B promotes organ growth in transgenic mice | Q34276940 |
| | Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas | Q34380511 |
| | Leucine. A possible regulator of protein turnover in muscle | Q34484538 |
| | Adaptation of Na+-H+ exchange in renal microvillus membrane vesicles. Role of dietary protein and uninephrectomy | Q34621469 |
| | Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate | Q34719423 |
| | Remission of renal disease: recounting the challenge, acquiring the goal | Q35028657 |
| | Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy | Q35132442 |
| | Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway | Q35503921 |
| | EGFR signaling promotes TGFβ-dependent renal fibrosis | Q35715849 |
| | Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite | Q35856833 |
| | Compensatory renal enlargement. Hypertrophy versus hyperplasia | Q35886216 |
| | Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis | Q36219361 |
| | Toward a unified theory of renal progression | Q36366880 |
| | Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor | Q36446896 |
| | mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking | Q36574743 |
| | The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology | Q37126069 |
| | Insulin resistance and protein metabolism in chronic hemodialysis patients | Q37367817 |
| | Classes of phosphoinositide 3-kinases at a glance | Q37608715 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2429-2444 | |
| P577 | publication date | 2015-05-18 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Phosphatidylinositol 3-kinase signaling determines kidney size | |
| P478 | volume | 125 | |